Dr. Paul Stoffels, chief scientific officer at Johnson & Johnson, joined Cheddar to discuss phase three COVID-19 vaccine trials.
More than 60,000 people worldwide have volunteered to be part of the study.
Dr. Paul Stoffels, chief scientific officer at Johnson & Johnson, joined Cheddar to discuss phase three COVID-19 vaccine trials.
More than 60,000 people worldwide have volunteered to be part of the study.
Five million doses of Chinese-made vaccine are set to arrive in Sao Paulo in October with phase-three trials starting soon.
Johnson & Johnson's Covid-19 vaccine candidate begins Phase 3 trials. Veuer’s Maria Mercedes Galuppo has the story.